Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)
Shanghai MicroPort MedBot (Group) Co., Ltd.
Building 1
Room 101, Area B 1601 Zhangdong Road China (Shanghai) Pilot Free Trade Zone
Shanghai
China
86 21 3895 4600
https://www.medbotsurgical.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 646
Description
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. It also offers spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery. In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities. Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. The company operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
Corporate governance
Shanghai MicroPort MedBot (Group) Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
